Prevalence of infection by HTLV-I/II among pregnant women and high-risk groups in the Peloponnese peninsula, Greece

International Journal of STD and AIDS

Volumn 17, Issue 8, 2006, Pages 543-546

  Tseliou, Parthenopi M ^a   Spanakis, Nicholas ^b   Spiliotakara, Anna ^a   Markogiannakis, Antonios ^b   Legakis, Nicholas J ^b   Tsakris, Athanassios ^b  

^a UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

ATTL; Blood donor; HTLV I II; INNO LIA; Intravenous drug users; Multitransfused patients; PCR; Pregnant women; Thalassaemic patients; WB

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CANCER PATIENT; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; ENZYME IMMUNOASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; GREECE; HEMATOLOGIC DISEASE; HIGH RISK POPULATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRIORITY JOURNAL; T CELL LEUKEMIA; THALASSEMIA; WESTERN BLOTTING;

BLOTTING, WESTERN; FEMALE; GREECE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKEMIA, T-CELL, HTLV-II-ASSOCIATED; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; THALASSEMIA;

EID: 33747834614     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646206778145541     Document Type: Article

References (23)

1. Bangham CR. Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control. Int J Hematol 2003;78:297-303
2. Murphy EL, Fridey J, Smith JW, et al. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators. Neurology 1997;48:315-20
3. Murphy EL, Glynn SA, Fridey J, et al. Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study. Arch Intern Med 1999;159:1485-91
4. Taylor GP. The epidemiology of HTLV-I in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(Suppl 1):S8-14
5. Sng EH, Thirumoorthy T, Levin A, Alexander S, Sng I, Blattner W. Evidence of HTLV-I infection in Singapore prostitutes. Int J STD AIDS 1991;2:172-5
6. Schreiber GB, Murphy EL, Horton JA, et al. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:263-71
7. HTLV European Research Network. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. J Acquir Immun Defic Syndr Hum Retrovirol 1996;13:68-77
8. Hall WW, Ishak R, Zhu SW, et al. Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(Suppl 1):S204-14
9. Dalekos GN, Zervou E, Karabini F, Elisaf M, Bourantas K, Siamopoulos KC. Prevalence of antibodies to human T-lymphotropic virus types I and II in northwestern Greece. Transfusion 1995;35:503-6
10. Zervou EK, Boumba DS, Liaskos C, Georgiadou S, Tsianos EV, Dalekos GN. Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: results of a 3-year prospective donor study (1995-1997). Eur J Intern Med 2003;14:39-44
11. Tseliou PM, Spanakis N, Spiliotakara A, Politis C, Legakis NJ, Tsakris A. HTLV-I and -II in southwestern Greece. Transfusion 2003;43:1641-2
12. Kokoris SI, Siakantaris MP, Kontopidou FN, et al. Adult T-cell leukemia/lymphoma (ATLL): report of two fully documented Hellenic patients. Leuk Lymphoma 2004;45:715-21
13. Mahieux R, Horal P, Mauclere P, et al. Human T-cell lymphotropic virus type I Gag indeterminate western blot patterns in central Africa: relationship to Plasmodium falciparum infection. J Clin Microbiol 2000;38:4049-57
14. Mahieux R, Pecon-Slattery J, Gessain A. Molecular characterization and phylogenetic analyses of a new, highly divergent simian T-cell lymphotropic virus type 1 (STLV-1marc1) in Macaca arctoides. J Virol 1997;71:6253-8
15. Tseliou PM, Spiliotakara A, Politis C, Spanakis N, Legakis NJ, Tsakris A. Prevalence of human T-cell lymphotropic virus-I/II-indeterminate reactivities in a Greek blood bank population. Transfus Med 2004;14:253-4
16. Mansuy JM, Schlegel L, Villeneuve L, Mengelle C, Magnaval JF. Seroprevalence of retroviral infections among pregnant women in Martinique (French West Indies). Am J Trop Hyg 1999;61:598-9
17. Bittencourt AL, Dourado I, Filho PB, et al. Human T-cell lymphotropic virus type 1 infection among pregnant women in northeastern Brazil. J Acquir Immune Defic Syndr 2001;26:490-4
18. Broutet N, de Queiroz Sousa A, Basilio FP, Sa HL, Simon F, Dabis F. Prevalence of HIV-1, HIV-2 and HTLV antibody, in Fortaleza, Ceara, Brazil, 1993-1994. Int J STD AIDS 1996;7:365-9
19. Politis C, Papaevangelou G, Sinakos Z, Trichopoulou E, Roumeliotou A. HTLV-I infection in multitransfused patients with thalassaemia. Transfusion 1989;29:561
20. Naman R, Klayme S, Naboulsi M, Mokhbat J, Jrabi O, Ramia S. HTLV-I and HTLV-II in volunteer blood donors and high-risk groups in Lebanon. J Infect 2002;45:29-31
21. Boni J, Bisset LR, Burckhardt JJ, et al. Prevalence of human T-cell leukaemia virus types I and II in Switzerland. J Med Virol 2004;72:328-37
22. Murphy EL, Figueroa JP, Gibbs WN, et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1989;111:555-60
23. Kaplan JE, Khabbaz RF, Murphy EL, et al. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:193-201